Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Benito

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Biotechnology|August 5, 2008
Intracellular routing of cytotoxic pancreatic-type ribonucleasesAntoni Benito, Maria Vilanova, Marc Ribó
Molecular Biosystems|August 2, 2006
On the track of antitumour ribonucleasesAntoni Benito, Marc Ribó, Maria Vilanova
Molecular Pharmaceutics|September 1, 2009
Bactericidal activity engineered on human pancreatic ribonuclease and onconaseGerard Torrent, Marc Ribó, Antoni Benito, et al.
Biopolymers|April 18, 2009
Mapping the stability clusters in bovine pancreatic ribonuclease ARoger Vilà, Antoni Benito, Marc Ribó, et al.
The FEBS Journal|March 8, 2006
Characterization of the dimerization process of a domain-swapped dimeric variant of human pancreatic ribonucleaseMontserrat Rodríguez, Antoni Benito, Marc Ribó, et al.
Current Medicinal Chemistry|March 10, 2018
Apoptin, A Versatile Protein with Selective Antitumor ActivityJessica Castro, Marc Ribo, Antoni Benito, et al.
Pharmaceutics|January 13, 2021
Strengths and Challenges of Secretory Ribonucleases as AntiTumor AgentsJessica Castro, Marc Ribó, Maria Vilanova, et al.
Investigational New Drugs|March 31, 2010
The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicityPere Tubert, Montserrat Rodríguez, Marc Ribó, et al.
Oncotarget|December 31, 2016
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of OnconaseAnna Vert, Jessica Castro, Marc Ribó, et al.
Oncotargets and Therapy|January 31, 2018
Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistanceAnna Vert, Jessica Castro, Marc Ribó, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Biotechnology|August 5, 2008
Intracellular routing of cytotoxic pancreatic-type ribonucleasesAntoni Benito, Maria Vilanova, Marc Ribó
Molecular Biosystems|August 2, 2006
On the track of antitumour ribonucleasesAntoni Benito, Marc Ribó, Maria Vilanova
Molecular Pharmaceutics|September 1, 2009
Bactericidal activity engineered on human pancreatic ribonuclease and onconaseGerard Torrent, Marc Ribó, Antoni Benito, et al.
Biopolymers|April 18, 2009
Mapping the stability clusters in bovine pancreatic ribonuclease ARoger Vilà, Antoni Benito, Marc Ribó, et al.
The FEBS Journal|March 8, 2006
Characterization of the dimerization process of a domain-swapped dimeric variant of human pancreatic ribonucleaseMontserrat Rodríguez, Antoni Benito, Marc Ribó, et al.
Current Medicinal Chemistry|March 10, 2018
Apoptin, A Versatile Protein with Selective Antitumor ActivityJessica Castro, Marc Ribo, Antoni Benito, et al.
Pharmaceutics|January 13, 2021
Strengths and Challenges of Secretory Ribonucleases as AntiTumor AgentsJessica Castro, Marc Ribó, Maria Vilanova, et al.
Investigational New Drugs|March 31, 2010
The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicityPere Tubert, Montserrat Rodríguez, Marc Ribó, et al.
Oncotarget|December 31, 2016
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of OnconaseAnna Vert, Jessica Castro, Marc Ribó, et al.
Oncotargets and Therapy|January 31, 2018
Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistanceAnna Vert, Jessica Castro, Marc Ribó, et al.
Pageof 4